Trial Profile
Multi-institutional phase II study of photodynamic therapy using ME2906 and PNL6405EPG for patients with local failure after chemoradiotherapy for esophageal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Talaporfin (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 05 Jun 2018 Results assessing efficacy of photodynamic therapy with talaporfin sodium presented at the Digestive Disease Week 2018.
- 06 Sep 2017 Status changed from active, no longer recruiting to completed.
- 16 Jan 2014 Status changed from recruiting to active, no longer recruiting, according to University Hospital Medical Information Network - Japan record.